BRCA2 and prostate carcinoma: Recently, an increasing number of studies have been performed to prove that the BRCA2-N372H variant is related to susceptibility to many other cancers, including multiple lymphoma, prostate cancer, advanced esophageal squamous cell carcinoma, familial colorectal tumors, and so on.